Vision® 8 Somnus

Vision® 8 Somnus



Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Perfringens Types C&D Bacterin-Toxoid

*Adjuvant - U.S. Patent Nos. 3,790,665 and 3,919,411




Indications
For use in healthy cattle as an aid in prevention of disease caused by Clostridium chauvoel, Clostridium septicum, Clostridium haemolyticum, Clostridium novyi, Clostridium sordellii, Clostridium perfringens Type C, Clostridium perfringens Type D, and Haemophilus somnus.

Administration and Dosage
The dose is 2 mL for cattle, administered subcutaneously. Repeat the dose in 3-4 weeks. In animals subject to exposure to C. haemolyticum, revaccinate every 5 to 6 months. Annual revaccination is recommended.

Shake well before using. Store at 35-45oF (2-7oC). Use entire contents when first opened. Do not faccinate within 21 days before slaughter. Anaphylactoid reactions may occur.

Antidote
Epinephrine. Contains formaldehyde as preservative.

Supplied
Code: B-959-10
10 dose
Code: B-959-50
50 dose
Code: B-959-250
250 dose







Product Label(s) and MSDS

For more information about Merck Animal Health Products call 1-800-441-8272.

TRUSTe European Safe Harbor certification
Validate TRUSTe privacy certification